Joseph Larosa - Aug 20, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP General Counsel and Secret
Signature
/s/**Joseph LaRosa
Stock symbol
REGN
Transactions as of
Aug 20, 2021
Transactions value $
-$4,846,906
Form type
4
Date filed
8/24/2021, 04:06 PM
Previous filing
Jul 7, 2021
Next filing
Dec 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $1.79M +10K +75.86% $179.13 23.2K Aug 20, 2021 Direct F1
transaction REGN Common Stock Tax liability -$4.37M -6.58K -28.36% $664.85 16.6K Aug 20, 2021 Direct F1
transaction REGN Common Stock Sale -$2.24M -3.38K -20.37% $661.80 13.2K Aug 23, 2021 Direct F1
transaction REGN Common Stock Sale -$27.3K -41 -0.31% $665.40 13.2K Aug 23, 2021 Direct F1, F2
transaction REGN Common Stock Sale -$666 -1 -0.01% $666.22 13.2K Aug 23, 2021 Direct F1
holding REGN Common Stock 3.19K Aug 20, 2021 2021 GRAT
holding REGN Common Stock 314 Aug 20, 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -10K -25% $0.00 30K Aug 20, 2021 Common Stock 10K $179.13 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 41 shares of Company stock on August 23, 2021 at prices ranging from $665.21 to $665.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price.
F3 The stock option award vests in four equal annual installments, commencing one year after the date of grant.